AI-powered podcast search and transcription. Find any topic, guest, or phrase across millions of episodes.

Product

Transcript Search
Browse Podcasts
Sponsor Tracking
Browse by Topic
Keyword Alerts
Recently Transcribed
Pricing

Company

About
Blog
Careers
Contact

Legal

Privacy Policy
Terms of Service
Cookie Policy

Author Interview: Professor Matthew Brown, 2026 | TrackPodcasts.com

education

Author Interview: Professor Matthew Brown, 2026

The IMID Forum·Feb 3, 2026·18:29·pending

About this Episode

Join Professor Peter Nash from the Griffith University in Brisbane, and Professor Matthew Brown, the Chief Scientific Officer at Genomics England, as they discuss his recent paper ‘Low uveitis rates in patients with axial spondyloarthritis treated with bimekizumab: Pooled results from Phase 2b/3 trials’.

Hosts & Guests

The Immune-Mediated Inflammatory Disease Forum

Host

No transcript available for this episode.

Author Interview: Professor Matthew Brown, 2026

The IMID Forum

0:00

18:29

Author Interview: Professor Matthew Brown, 2026

About this Episode

Hosts & Guests

More from The IMID Forum

Discussing PsA: Bimekizumab in PsA: Clinical efficacy and updated safety profile

Author Interview: Professor Helena Marzo-Ortega, March 2026

Discussing RA: Malignancy risk in patients with RA and the evolution of JAKi pre...

Discussing axSpA: Symptom duration impact on bimekizumab efficacy and therapeuti...